Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane

Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of hematology 2003-04, Vol.82 (4), p.223-227
Hauptverfasser: DEVIREN, A, YALMAN, N, HACIHANEFIOGLU, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 227
container_issue 4
container_start_page 223
container_title Annals of hematology
container_volume 82
creator DEVIREN, A
YALMAN, N
HACIHANEFIOGLU, S
description Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentation, deafness, and renal, ocular, genital, and cardiac defects. The cardinal clinical feature is a severe progressive pancytopenia. The overall aim of our study was to compare two different alkylating agents that would permit rapid and unequivocal detection of FA. A total of 271 patients underwent nitrogen mustard (NTM) and diepoxybutane (DEB) tests in our laboratory; baseline chromosomal breakage was studied for all of them. After the results of the chromosomal breakage studies, 72 patients were diagnosed as affected and 136 patients as unaffected by FA. We also studied 63 family members of FA patients. According to our study, NTM seems more specific to identify chromosomal breakages in FA parents than DEB.
doi_str_mv 10.1007/s00277-003-0614-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_733006160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2093612331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-48224f71a349aca91b40c841b3ec0246740b84c97a8424ad6ef00176c726d19d3</originalsourceid><addsrcrecordid>eNpFkMFOwzAMhiMEYmPwAFxQhcSx4CRu0x7RYIA0wQXOUZomU6a1GUkrsbcn0ybNFx_8_bb1EXJL4ZECiKcIwITIAXgOJcUcz8iUImc5FBWekynUvM6LVBNyFeMagLIK2SWZUCZACIZT8vnirDXB9INTm6x1atX76GLmbbZQvfa9y1RvOqeyZpf1bgh-ZfqsG-OgQptGbcqYrf_bNeOQwGtyYdUmmptjn5Gfxev3_D1ffr19zJ-XueYFDjlWjKEVVHGslVY1bRB0hbThRgPDUiA0FepaqPQvqrY0Nj0vSi1Y2dK65TNyf9i7Df53NHGQaz-GPp2UgnNINkpIED1AOvgYg7FyG1ynwk5SkHuB8iBQJoFyL1BiytwdF49NZ9pT4mgsAQ9HQEWtNjYkSy6eOBRYiFrwf-Ikd2c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733006160</pqid></control><display><type>article</type><title>Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>DEVIREN, A ; YALMAN, N ; HACIHANEFIOGLU, S</creator><creatorcontrib>DEVIREN, A ; YALMAN, N ; HACIHANEFIOGLU, S</creatorcontrib><description>Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentation, deafness, and renal, ocular, genital, and cardiac defects. The cardinal clinical feature is a severe progressive pancytopenia. The overall aim of our study was to compare two different alkylating agents that would permit rapid and unequivocal detection of FA. A total of 271 patients underwent nitrogen mustard (NTM) and diepoxybutane (DEB) tests in our laboratory; baseline chromosomal breakage was studied for all of them. After the results of the chromosomal breakage studies, 72 patients were diagnosed as affected and 136 patients as unaffected by FA. We also studied 63 family members of FA patients. According to our study, NTM seems more specific to identify chromosomal breakages in FA parents than DEB.</description><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-003-0614-4</identifier><identifier>PMID: 12707724</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Alkylating Agents - therapeutic use ; Anemias. Hemoglobinopathies ; Biological and medical sciences ; Chromosome Breakage ; Diagnosis, Differential ; Diseases of red blood cells ; Epoxy Compounds ; Fanconi Anemia - diagnosis ; Fanconi Anemia - genetics ; Hematologic and hematopoietic diseases ; Humans ; Lymphocytes - drug effects ; Mechlorethamine ; Medical sciences</subject><ispartof>Annals of hematology, 2003-04, Vol.82 (4), p.223-227</ispartof><rights>2003 INIST-CNRS</rights><rights>Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-48224f71a349aca91b40c841b3ec0246740b84c97a8424ad6ef00176c726d19d3</citedby><cites>FETCH-LOGICAL-c354t-48224f71a349aca91b40c841b3ec0246740b84c97a8424ad6ef00176c726d19d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14745797$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12707724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DEVIREN, A</creatorcontrib><creatorcontrib>YALMAN, N</creatorcontrib><creatorcontrib>HACIHANEFIOGLU, S</creatorcontrib><title>Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><description>Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentation, deafness, and renal, ocular, genital, and cardiac defects. The cardinal clinical feature is a severe progressive pancytopenia. The overall aim of our study was to compare two different alkylating agents that would permit rapid and unequivocal detection of FA. A total of 271 patients underwent nitrogen mustard (NTM) and diepoxybutane (DEB) tests in our laboratory; baseline chromosomal breakage was studied for all of them. After the results of the chromosomal breakage studies, 72 patients were diagnosed as affected and 136 patients as unaffected by FA. We also studied 63 family members of FA patients. According to our study, NTM seems more specific to identify chromosomal breakages in FA parents than DEB.</description><subject>Alkylating Agents - therapeutic use</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Biological and medical sciences</subject><subject>Chromosome Breakage</subject><subject>Diagnosis, Differential</subject><subject>Diseases of red blood cells</subject><subject>Epoxy Compounds</subject><subject>Fanconi Anemia - diagnosis</subject><subject>Fanconi Anemia - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Lymphocytes - drug effects</subject><subject>Mechlorethamine</subject><subject>Medical sciences</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkMFOwzAMhiMEYmPwAFxQhcSx4CRu0x7RYIA0wQXOUZomU6a1GUkrsbcn0ybNFx_8_bb1EXJL4ZECiKcIwITIAXgOJcUcz8iUImc5FBWekynUvM6LVBNyFeMagLIK2SWZUCZACIZT8vnirDXB9INTm6x1atX76GLmbbZQvfa9y1RvOqeyZpf1bgh-ZfqsG-OgQptGbcqYrf_bNeOQwGtyYdUmmptjn5Gfxev3_D1ffr19zJ-XueYFDjlWjKEVVHGslVY1bRB0hbThRgPDUiA0FepaqPQvqrY0Nj0vSi1Y2dK65TNyf9i7Df53NHGQaz-GPp2UgnNINkpIED1AOvgYg7FyG1ynwk5SkHuB8iBQJoFyL1BiytwdF49NZ9pT4mgsAQ9HQEWtNjYkSy6eOBRYiFrwf-Ikd2c</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>DEVIREN, A</creator><creator>YALMAN, N</creator><creator>HACIHANEFIOGLU, S</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20030401</creationdate><title>Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane</title><author>DEVIREN, A ; YALMAN, N ; HACIHANEFIOGLU, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-48224f71a349aca91b40c841b3ec0246740b84c97a8424ad6ef00176c726d19d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Alkylating Agents - therapeutic use</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Biological and medical sciences</topic><topic>Chromosome Breakage</topic><topic>Diagnosis, Differential</topic><topic>Diseases of red blood cells</topic><topic>Epoxy Compounds</topic><topic>Fanconi Anemia - diagnosis</topic><topic>Fanconi Anemia - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Lymphocytes - drug effects</topic><topic>Mechlorethamine</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DEVIREN, A</creatorcontrib><creatorcontrib>YALMAN, N</creatorcontrib><creatorcontrib>HACIHANEFIOGLU, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DEVIREN, A</au><au>YALMAN, N</au><au>HACIHANEFIOGLU, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane</atitle><jtitle>Annals of hematology</jtitle><addtitle>Ann Hematol</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>82</volume><issue>4</issue><spage>223</spage><epage>227</epage><pages>223-227</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><abstract>Fanconi anemia (FA) is an autosomal recessive inherited disorder which is associated with a variety of congenital anomalies. These include morphometric abnormalities involving mainly the head and face, skeletal malformations particularly of the radial ray, growth retardation, abnormal skin pigmentation, deafness, and renal, ocular, genital, and cardiac defects. The cardinal clinical feature is a severe progressive pancytopenia. The overall aim of our study was to compare two different alkylating agents that would permit rapid and unequivocal detection of FA. A total of 271 patients underwent nitrogen mustard (NTM) and diepoxybutane (DEB) tests in our laboratory; baseline chromosomal breakage was studied for all of them. After the results of the chromosomal breakage studies, 72 patients were diagnosed as affected and 136 patients as unaffected by FA. We also studied 63 family members of FA patients. According to our study, NTM seems more specific to identify chromosomal breakages in FA parents than DEB.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>12707724</pmid><doi>10.1007/s00277-003-0614-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0939-5555
ispartof Annals of hematology, 2003-04, Vol.82 (4), p.223-227
issn 0939-5555
1432-0584
language eng
recordid cdi_proquest_journals_733006160
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Alkylating Agents - therapeutic use
Anemias. Hemoglobinopathies
Biological and medical sciences
Chromosome Breakage
Diagnosis, Differential
Diseases of red blood cells
Epoxy Compounds
Fanconi Anemia - diagnosis
Fanconi Anemia - genetics
Hematologic and hematopoietic diseases
Humans
Lymphocytes - drug effects
Mechlorethamine
Medical sciences
title Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A30%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20diagnosis%20of%20Fanconi%20anemia%20by%20nitrogen%20mustard%20and%20diepoxybutane&rft.jtitle=Annals%20of%20hematology&rft.au=DEVIREN,%20A&rft.date=2003-04-01&rft.volume=82&rft.issue=4&rft.spage=223&rft.epage=227&rft.pages=223-227&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-003-0614-4&rft_dat=%3Cproquest_cross%3E2093612331%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733006160&rft_id=info:pmid/12707724&rfr_iscdi=true